Long-term Significance (15 years) of Pathological Complete Response after Dose-dense Neoadjuvant Chemotherapy in Breast Cancer

MLA

Philippe Chollet, et al. “Long-Term Significance (15 Years) of Pathological Complete Response after Dose-Dense Neoadjuvant Chemotherapy in Breast Cancer.” The Breast Journal, vol. 19, June 2013, pp. 448–50. EBSCOhost, https://doi.org/10.1111/tbj.12131.

APA

Philippe Chollet, Catherine Abrial, Xavier Durando, Qian Wang-Lopez, Marie-Ange Mouret-Reynier, Fabrice Kwiatkowski, Pascale Dubray-Longeras, Frédérique Penault-Llorca, Pierre Gimbergues, Emilie Gadéa, Eloise Planchat, & Hervé Curé. (2013). Long-term Significance (15 years) of Pathological Complete Response after Dose-dense Neoadjuvant Chemotherapy in Breast Cancer. The Breast Journal, 19, 448–450. https://doi.org/10.1111/tbj.12131

Chicago

Philippe Chollet, Catherine Abrial, Xavier Durando, Qian Wang-Lopez, Marie-Ange Mouret-Reynier, Fabrice Kwiatkowski, Pascale Dubray-Longeras, et al. 2013. “Long-Term Significance (15 Years) of Pathological Complete Response after Dose-Dense Neoadjuvant Chemotherapy in Breast Cancer.” The Breast Journal 19 (June): 448–50. doi:10.1111/tbj.12131.